Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 2

Interventions

pembrolizumab 521Specimen Handling 383Carboplatin 376Magnetic Resonance Spectroscopy 334Cisplatin 331Nivolumab 309Cyclophosphamide 298Radiotherapy 257Paclitaxel 254Biopsy 235Gemcitabine 234Bevacizumab 218Dexamethasone 169durvalumab 167Oxaliplatin 163Capecitabine 159Rituximab 156Fluorouracil 149venetoclax 147Docetaxel 147atezolizumab 143Drug Therapy 143Etoposide 141Doxorubicin 134Ipilimumab 129Prednisone 121Radiosurgery 120Lenalidomide 118Leucovorin 113fludarabine 109

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Chemoradiotherapy, Adjuvant × 1 year × Clear all
NCT03480672 2026-02-17

Postoperative aRCH With Cisplatin Versus aRCH With Cisplatin and Pembrolizumab in Locally Advanced Head and Neck Squamous Cell Carcinoma

University of Leipzig

Phase 2 Completed
211 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05272696 2025-07-01

Pembrolizumab and Induction Chemotherapy in Locally Advanced HNSCC

Guangdong Provincial People's Hospital

Phase 2 Recruiting
86 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡